Adviteeya Narasimhan Dixit, MD
NPI 1801044342 · Pulmonary Disease Physician · Atlanta, GA
Enrolled with Medicare as Practitioner - Pulmonary Disease · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1801044342
- Entity type
- Individual
- Primary specialty
- Pulmonary Disease PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD
- Sex
- Male
- Sole proprietor
- Yes
- License
- 079833 (GA)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure28% of score
17 yrs in NPPES registry
- Profile completeness28% of score
100% of core fields populated
- Practice footprint17% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)28% of score
988 Medicare services, 2024 (ranked within specialty)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 130 | $120 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 111 | $83 |
| Test to Examine How Well the Lungs Exchange Gases94729 | 104 | $41 |
| Test to Determine Lung Volumes Using Sensors94726 | 98 | $41 |
| Test to Measure Rate of Airflow94375 | 85 | $30 |
| Test for Exercise-Induced Lung Stress94618 | 76 | $31 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 25 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Albuterol Sulfatebrand: Albuterol Sulfate Hfa | 266 | 98 |
| Fluticasone/Umeclidin/Vilanterbrand: Trelegy Ellipta | 114 | 28 |
| Fluticasone/Vilanterolbrand: Breo Ellipta | 107 | 25 |
| Methylprednisolone | 62 | 45 |
| Umeclidinium Bromidebrand: Incruse Ellipta | 61 | 16 |
| Fluticasone Propion/Salmeterolbrand: Fluticasone-Salmeterol | 58 | 16 |
Practice location
Mailing address
Registry dates
- Enumerated
- 2008-09-08
- Last updated
- 2019-06-11
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.